Arnie Phifer | January 18, 2017
As part of the launch of a new research program in Health-Related Behavioral Sciences, the University of Notre Dame’s Advanced Diagnostics & Therapeutics initiative has made its first award to support an investigation of why patients with Type 2 diabetes don’t always follow their prescribed medical regimens.
The study, led by Guangjian Zhang, Associate Professor of Psychology, will collect pilot data on adherence to recommendations from physicians--regarding medication, diet, physical activities, sleep, and self-administered blood tests--in forty Type 2 diabetes patients and develop statistical methods to analyze the intensive longitudinal data that are produced.
“Our long term goal is to contribute to the understanding, prevention, and treatment of lifestyle-related chronic diseases,” said Zhang, “and diabetes is an important place to start.”
The World Health Organization estimates that there are 422 million people in the world living with diabetes, and work by other researchers suggest that only 7.3% of diabetes patients fully meet all three goals of controlling blood sugar, blood pressure, and blood lipid levels.
“We think one contributing factor for patient nonadherence is the lack of effective self-management components in most diabetes treatment plans,” Zhang continued.